Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Stamford

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Organic Letters|May 21, 2010
Formal olefination and acylaziridination of imidazolonesXing Dai, Michael W Miller, Andrew W Stamford
Organic Letters|May 30, 2013
A novel method for the preparation of 4-arylimidazolonesDuane E DeMong, Irene Ng, Michael W Miller, et al.
Topics in Current Chemistry|June 8, 2011
Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitorsDaniel F Wyss, Yu-Sen Wang, Hugh L Eaton, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-onesJoel M Harris, Bernard R Neustadt, Hongtao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitorU Iserloh, J Pan, A W Stamford, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonistsH S Ahn, L Arik, G Boykow, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Potent pyrrolidine- and piperidine-based BACE-1 inhibitorsU Iserloh, Y Wu, J N Cumming, et al.
European Journal of Pharmacology|March 8, 2014
Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behaviorRobert A Hodgson, Deborra Mullins, Sherry X Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2008
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidinesBernard R Neustadt, Hong Liu, Jinsong Hao, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidinesBernard R Neustadt, Jinsong Hao, Neil Lindo, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Organic Letters|May 21, 2010
Formal olefination and acylaziridination of imidazolonesXing Dai, Michael W Miller, Andrew W Stamford
Organic Letters|May 30, 2013
A novel method for the preparation of 4-arylimidazolonesDuane E DeMong, Irene Ng, Michael W Miller, et al.
Topics in Current Chemistry|June 8, 2011
Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitorsDaniel F Wyss, Yu-Sen Wang, Hugh L Eaton, et al.
Bioorganic & Medicinal Chemistry Letters|March 15, 2011
Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-onesJoel M Harris, Bernard R Neustadt, Hongtao Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitorU Iserloh, J Pan, A W Stamford, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonistsH S Ahn, L Arik, G Boykow, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Potent pyrrolidine- and piperidine-based BACE-1 inhibitorsU Iserloh, Y Wu, J N Cumming, et al.
European Journal of Pharmacology|March 8, 2014
Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behaviorRobert A Hodgson, Deborra Mullins, Sherry X Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2008
Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidinesBernard R Neustadt, Hong Liu, Jinsong Hao, et al.
Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidinesBernard R Neustadt, Jinsong Hao, Neil Lindo, et al.
Pageof 4